RAAS

(redirected from Renin-angiotensin-aldosterone system)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia.
Related to Renin-angiotensin-aldosterone system: Atrial natriuretic peptide
AcronymDefinition
RAASRenin-Angiotensin-Aldosterone System
RAASResort Accommodation and Sales
RAASRegión Autónoma del Atlántico Sur
RAASReporting As A Service
RAASRunway Awareness and Advisory System
RAASRussian Academy of Agricultural Sciences
RAASRegulatory Audit Archive System
RAASRemote Aerodrome Advisory Service (aviation telecommunications; Canada)
RAASRomanian Association for American Studies
RAASRemedial Action Assessment System
RAASRare Antibody Antigen Supply, Inc. (Agoura Hills, CA)
RAASReference Ambient Air Sampler
RAASRemote Access Aviation System
RAASReport Analysis and Archive System (Domestic Nuclear Detection Office)
RAASRobotic Armored Assault System
RAASRegional Area Augmentation System
RAASRoyal Alexandra and Albert School (UK)
RAASRaytheon Airline Aviation Services LLC
RAASRisk Assessment and Application System
RAASReadiness-as-a-Service
RAASright ascension of the apparent sun
RAASResearch Analyst Assessment Specialist
RAASRISC Advanced Architecture Server
RAASResource as a Solution (Canada)
RAASRecruitment as a Service
References in periodicals archive ?
Dudley Jr, "The renin-angiotensin-aldosterone system (RAAS) and cardiac arrhythmias," Heart Rhythm, vol.
When Vitamin D is sufficient, the Vitamin D receptor would bind to the ligand site of the c-AMP response element binding protein and occupy the binding site, thereby blocking their binding and activation of downstream gene promoters.[19] To study whether the regulation of the renin-angiotensin-aldosterone system by 1,25(OH)[sub]2D[sub]3 was dependent on calcium-phosphorus metabolism, Zhou et al .
Wang et al., "Renin-angiotensin system blockade for the risk of cancer and death," Journal of the Renin-Angiotensin-Aldosterone System, vol.
The reduction in effective arterial blood volume caused by heart failure, kidney disease or severe hypoproteinemia, activates the renin-angiotensin-aldosterone system. This physiological response is called secondary hyperaldosteronism or hyperreninemic hyperaldosteronism (DJAJADININGRAT-LAANEN et al., 2011).
Abbreviations AKI: Acute kidney Injury APK: Acute Page Kidney RAAS: Renin-angiotensin-aldosterone system HTN: Hypertension.
Regarding antihypertensive drug selection, the new statement endorses a focus on treating hypertensive patients with established coronary artery disease with a beta-blocker, a renin-angiotensin-aldosterone system blocker such as an ACE inhibitor or angiotensin-receptor blocker, and a thiazide or thiazide-like diuretic.
Recent Update of Renin-angiotensin-aldosterone System in the Pathogenesis of Hypertension.
Among the predisposing genetic factors, renin-angiotensin-aldosterone system (RAAS) disruption is clearly involved in ESRD development [3].
ACE-Is act by inhibiting the renin-angiotensin-aldosterone system (RAAS), specifically the conversion of angiotensin-I to angiotensin-II, thereby causing vasodilatation of the efferent renal arterioles and thus decreasing the intraglomerular pressures [17].
However the role of renin-angiotensin-aldosterone system (RAAS) blocking agents, angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) in the pathophysiology of CIN remains controversial, as the available literature is conflicted and discordant.